Home>Catalog Product>Biosimilar Benchmark Antibodies

Sales Promotion Get free trial
Contact Us Phone:+001-86-15307149771 Email:info@dimabio.com
Please leave your suggestion or opinion, we will reply you as soon as possible, thank you!×

Anti-CD47 (magrolimab biosimilar) mAb

Product Overview
Common Name Hu5F9-G4
Buffer Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Guarantee 12 months from date of dispatch
Catalog Number BME100001
Package 50 μg $80.00 ; 100 μg $160.00
Delivery In Stock
Synonyms CD47, MER6, IAP
Host Species Chimeric Humanized
IgG type IgG4
Clonality Monoclonal
Formulation Powder
Purification Purified from cell culture supernatant by affinity chromatography
Reactivity Human
Applications ELISA, Flow Cyt
Recommended Dilutions ELISA 1:5000-10000, Flow Cyt 1:100
Storage Store at -20°C (Avoid repeated freezing and thawing)
Usage Research use only


Figure 1. ELISA plate pre-coated by 2 μg/ml (100 μl/well) Human CD47, mFc-His tagged protein (PME100008) can bind Anti-CD47 (Neutralizing antibody clone Hu5F9-G4) in a linear range of 0.061-1.606 ng/ml.


Figure 2. HEK293 cell line transfected with irrelevant protein (B) and human CD47(A) were surface stained with anti-CD47 neutralizing antibody 1μg/ml (magrolimab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.

Background Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Data Download
Datasheet Download COA Download
MSDS Download
Please leave your mobile phone number, and we will contact you as soon as possible. Thank you!×


AddressWuhan institute of Biotechnology B7, Biolake No.666 Gaoxin Road, Wuhan, Hubei, China



Follow Us On